Literature DB >> 23600492

Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study.

Michael A Thomashow1, Daichi Shimbo, Megha A Parikh, Eric A Hoffman, Jens Vogel-Claussen, Katja Hueper, Jessie Fu, Chia-Ying Liu, David A Bluemke, Corey E Ventetuolo, Margaret F Doyle, R Graham Barr.   

Abstract

RATIONALE: Basic research implicates alveolar endothelial cell apoptosis in the pathogenesis of chronic obstructive pulmonary disease (COPD) and emphysema. However, information on endothelial microparticles (EMPs) in mild COPD and emphysema is lacking.
OBJECTIVES: We hypothesized that levels of CD31(+) EMPs phenotypic for endothelial cell apoptosis would be elevated in COPD and associated with percent emphysema on computed tomography (CT). Associations with pulmonary microvascular blood flow (PMBF), diffusing capacity, and hyperinflation were also examined.
METHODS: The Multi-Ethnic Study of Atherosclerosis COPD Study recruited participants with COPD and control subjects age 50-79 years with greater than or equal to 10 pack-years without clinical cardiovascular disease. CD31(+) EMPs were measured using flow cytometry in 180 participants who also underwent CTs and spirometry. CD62E(+) EMPs phenotypic for endothelial cell activation were also measured. COPD was defined by standard criteria. Percent emphysema was defined as regions less than -950 Hounsfield units on full-lung scans. PMBF was assessed on gadolinium-enhanced magnetic resonance imaging. Hyperinflation was defined as residual volume/total lung capacity. Linear regression was used to adjust for potential confounding factors.
MEASUREMENTS AND MAIN RESULTS: CD31(+) EMPs were elevated in COPD compared with control subjects (P = 0.03) and were notably increased in mild COPD (P = 0.03). CD31(+) EMPs were positively related to percent emphysema (P = 0.045) and were inversely associated with PMBF (P = 0.047) and diffusing capacity (P = 0.01). In contrast, CD62E(+) EMPs were elevated in severe COPD (P = 0.003) and hyperinflation (P = 0.001).
CONCLUSIONS: CD31(+) EMPs, suggestive of endothelial cell apoptosis, were elevated in mild COPD and emphysema. In contrast, CD62E(+) EMPs indicative of endothelial activation were elevated in severe COPD and hyperinflation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600492      PMCID: PMC3735242          DOI: 10.1164/rccm.201209-1697OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  46 in total

1.  Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition.

Authors:  John A Marwick; Christopher S Stevenson; June Giddings; William MacNee; Keith Butler; Irfan Rahman; Paul A Kirkham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-12-16       Impact factor: 5.464

2.  Elevated plasma endothelial microparticles in multiple sclerosis.

Authors:  A Minagar; W Jy; J J Jimenez; W A Sheremata; L M Mauro; W W Mao; L L Horstman; Y S Ahn
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

3.  Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.

Authors:  Salud Santos; Victor I Peinado; Josep Ramirez; Jaime Morales-Blanhir; Ricardo Bastos; Josep Roca; Robert Rodriguez-Roisin; Joan A Barbera
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

4.  Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease.

Authors:  Víctor I Peinado; Josep Ramírez; Josep Roca; Robert Rodriguez-Roisin; Joan A Barberà
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-20       Impact factor: 6.914

5.  Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study.

Authors:  Katja Hueper; Megha A Parikh; Martin R Prince; Christian Schoenfeld; Chia Liu; David A Bluemke; Stephen M Dashnaw; Thomas A Goldstein; Eric A Hoffman; Joao A Lima; Jan Skrok; Jie Zheng; R Graham Barr; Jens Vogel-Claussen
Journal:  Invest Radiol       Date:  2013-04       Impact factor: 6.016

6.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

Review 7.  Endothelial microparticles as markers of endothelial dysfunction.

Authors:  Lawrence L Horstman; Wenche Jy; Joaquin J Jimenez; Yeon S Ahn
Journal:  Front Biosci       Date:  2004-05-01

Review 8.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

9.  Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.

Authors:  Philipp Eickhoff; Arschang Valipour; Dora Kiss; Martin Schreder; Leyla Cekici; Kora Geyer; Robab Kohansal; Otto C Burghuber
Journal:  Am J Respir Crit Care Med       Date:  2008-10-03       Impact factor: 21.405

10.  Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen.

Authors:  D L Simmons; C Walker; C Power; R Pigott
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

View more
  53 in total

1.  A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.

Authors:  J Stolk; W Broekman; T Mauad; J J Zwaginga; H Roelofs; W E Fibbe; J Oostendorp; I Bajema; M I M Versteegh; C Taube; P S Hiemstra
Journal:  QJM       Date:  2016-01-27

2.  Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding.

Authors:  Eleftheria Letsiou; Saad Sammani; Wei Zhang; Tong Zhou; Hector Quijada; Liliana Moreno-Vinasco; Steven M Dudek; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

3.  Adaptive quantification and longitudinal analysis of pulmonary emphysema with a hidden Markov measure field model.

Authors:  Yrjo Hame; Elsa D Angelini; Eric A Hoffman; R Graham Barr; Andrew F Laine
Journal:  IEEE Trans Med Imaging       Date:  2014-04-15       Impact factor: 10.048

4.  Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.

Authors:  Katja Hueper; Jens Vogel-Claussen; Megha A Parikh; John H M Austin; David A Bluemke; James Carr; Jiwoong Choi; Thomas A Goldstein; Antoinette S Gomes; Eric A Hoffman; Steven M Kawut; Joao Lima; Erin D Michos; Wendy S Post; Ming Jack Po; Martin R Prince; Kiang Liu; Dan Rabinowitz; Jan Skrok; Ben M Smith; Karol Watson; Youbing Yin; Alan M Zambeli-Ljepovic; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

5.  A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes.

Authors:  Michael H Cho; Peter J Castaldi; Craig P Hersh; Brian D Hobbs; R Graham Barr; Ruth Tal-Singer; Per Bakke; Amund Gulsvik; Raúl San José Estépar; Edwin J R Van Beek; Harvey O Coxson; David A Lynch; George R Washko; Nan M Laird; James D Crapo; Terri H Beaty; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

Review 6.  A Decade of National Heart, Lung, and Blood Institute Programs Supporting COPD Research and Education .

Authors:  Lisa Postow; Antonella Punturieri; Thomas L Croxton; Gail G Weinmann; James P Kiley
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

7.  Phagocytosis of microparticles by alveolar macrophages during acute lung injury requires MerTK.

Authors:  Michael P Mohning; Stacey M Thomas; Lea Barthel; Kara J Mould; Alexandria L McCubbrey; S Courtney Frasch; Donna L Bratton; Peter M Henson; William J Janssen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-21       Impact factor: 5.464

8.  Pulmonary emphysema subtypes on computed tomography: the MESA COPD study.

Authors:  Benjamin M Smith; John H M Austin; John D Newell; Belinda M D'Souza; Anna Rozenshtein; Eric A Hoffman; Firas Ahmed; R Graham Barr
Journal:  Am J Med       Date:  2013-10-09       Impact factor: 4.965

Review 9.  Should mild COPD be treated? Evidence for early pharmacological intervention.

Authors:  Amany F Elbehairy; Katherine A Webb; J Alberto Neder; J Alberto Neder; Denis E O'Donnell
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

10.  Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.

Authors:  Meghan E Fitzpatrick; Mehdi Nouraie; Matthew R Gingo; Danielle Camp; Cathy J Kessinger; James B Sincebaugh; Andrew Clarke; John W Ries; Eric C Kleerup; Lawrence Kingsley; Alison Morris
Journal:  AIDS       Date:  2016-06-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.